The current national coverage determination for cardiac pacemakers is outdated and the clinical indications for these devices should be revised, according to several professional societies and other stakeholders.
CMS opened a national coverage analysis Jan. 24 in response to a Dec. 18 letter from the Heart...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?